Cardiovascular Renal Metabolic

BEST-CLI Sub-Set Analysis

Alik Farber

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
The Rise of CVRM Medicine: Managing Common Co-morbidities as One

Neha Pagidipati, Carel Le Roux, Lawrence A Leiter, et al

Martin Berger , Nikolaus Marx , Katharina Marx-Schütt

Read time: 16m 8s
Bariatric Surgery: Reduced CVD Risk via PREVENT Equations

Danxia Yu

Watch time: 5m 30s

Kayo Waki , Shuya Iwata , Toshimasa Yamauchi , et al

Read time: 13m 32s
ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s
ACC 25 Late-Breaking Discussion: The SOUL Trial

Harriette Van Spall, Darren McGuire

Watch time: 20m 59s
Ep 131: Beyond Weight Loss: GLP-1s as Cardioprotective Game-Changers in 2025

Listen time: 40m 45s
ACC 25 Late-Breaking Discussion: The STRIDE Trial

Harriette Van Spall, Marc P Bonaca

Watch time: 11m 44s
Tirzepatide Shows Kidney Benefits in T2D: SURPASS Trials Analysis

Ellen Apperloo

Watch time: 6m 37s

Radcliffe CVRM

Redefining Obesity: Beyond BMI

Robert Eckel

Watch time: 13m 6s

David Wheeler, Sunita Bavanandan , Carol Pollock et al

Muthiah Vaduganathan

Giuseppe Rosano , David Quek , Felipe Martínez

Read time: 10m

Sydney Tang , Chuan-Ming Hao, Kieran McCafferty et al

Stefan Anker, Shelley Zieroth, Andrew JS Coats, et al

Watch time: 5h 14m 55s (31 videos)

Stephen Fishbane, Adeera Levin, Kieran McCafferty et al

Watch time: 58m 34s (4 videos)

Lee Kaplan, Fatima Cody Stanford, Filip Knop, et al

Clara Bonanad Lozano , Anjay Rastogi

Andrew JS Coats, Stefan Anker

Tina Vilsbøll, Neha Pagidipati, John Buse, et al

Watch time: 2h (19 videos)

Robert Rosenson, Gerald Watts

Watch time: 8m 53s (5 videos)

David K Ryan , Debasish Banerjee , Fadi Jouhra

Read time: 10m

Media

AHA 23: Preventive Cardiology in 2023

Michael Honigberg

Watch time: 7m 3s
AHA 23: 3 Trials That Will Change My Practice

Dipti Itchhaporia

Watch time: 7m 20s
AHA 23 Late-Breaker Discussion: The SELECT Trial

A Michael Lincoff , Harriette Van Spall

Watch time: 21m 35s
CardioNerds @AHA23: Presidential Advisory on CKM Health

Ramy Doss, Chiadi Ndumele

Watch time: 14m 32s

Stefan Anker, Giuseppe Rosano, Javier de Juan Bagudá, et al

Watch time: 15h 45m 20s (18 videos)
ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod

Watch time: 13m 24s
ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi

Watch time: 13m 28s
ERA 23: REVEAL-CKD: Underdiagnosis of CKD

Navdeep Tangri

Watch time: 3m 32s
ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems

Watch time: 7m 7s

James Burton, Shelley Zieroth, Clara Bonanad Lozano , et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, Kerri L Cavanaugh, John Spertus, et al

Obesity Management Strategies in 2023

Harold Bays

Watch time: 17m 7s

Media

Broadcast

Cardiovascular Renal Metabolic

Prevention & Chronic Conditions
The Rise of CVRM Medicine: Managing Common Co-morbidities as One

Neha Pagidipati, Carel Le Roux, Lawrence A Leiter, et al

BEST-CLI Sub-Set Analysis

Alik Farber

ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s
Bariatric Surgery: Reduced CVD Risk via PREVENT Equations

Danxia Yu

Watch time: 5m 30s
Pediatric Heart Failure, Part 1

Charles E Canter, Patrick Jay

Watch time: 9m 34s
ESC 2019: Wrap-up - Part 1 - Dr Nicolas van Mieghem

Nicolas M Van Mieghem

Watch time: 7m 19s
ACC 25 Late-Breaking Discussion: The SOUL Trial

Harriette Van Spall, Darren McGuire

Watch time: 20m 59s
ACC 25 Late-Breaking Discussion: The STRIDE Trial

Harriette Van Spall, Marc P Bonaca

Watch time: 11m 44s
Integrating New Weight Management Therapies into Comprehensive CVD Care

Steven E Nissen

Watch time: 7m 16s
Redefining Obesity: Beyond BMI

Robert Eckel

Watch time: 13m 6s
Tirzepatide Shows Kidney Benefits in T2D: SURPASS Trials Analysis

Ellen Apperloo

Watch time: 6m 37s
Optimisation of Guideline-directed Medical Therapy in Cardiorenal Patients

Ileana L Piña, David Wheeler, Iris Beldhuis, et al

Watch time: 45m 39s

Articles

Cardiovascular Disease and Type 2 Diabetes

Martin Berger

,

Nikolaus Marx

,

Katharina Marx-Schütt

,

Published:

15 April 2025

Citation:

European Cardiology Review 2025;20:e09.

DOI:

https://doi.org/10.15420/ecr.2024.29
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 165
  • Downloads: Downloads 24
  • Read time: 16m 8s

Digital Therapeutics and Type 2 Diabetes

Kayo Waki

,

Shuya Iwata

,

Toshimasa Yamauchi

,

Masaomi Nangaku

,

Kazuhiko Ohe

,

Published:

10 April 2025

Citation:

Journal of Asian Pacific Society of Cardiology 2025;4:e09.

DOI:

https://doi.org/10.15420/japsc.2024.34
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 184
  • Downloads: Downloads 16
  • Read time: 13m 32s

The True Obesity Paradox: Obese and Malnourished?

Mohammed El-Sheikh

,

Nora Olsen El Caidi

,

Aginsha Kandiah

,

Sandra Henriette Tonning

,

Ida Arentz Taraldsen

,

Frederik Dencker Wisborg

,

Ove Andersen

,

Jens Dahlgaard Hove

,

Johannes Grand

,

Published:

19 February 2025

Citation:

Cardiac Failure Review 2025;11:e03.

DOI:

https://doi.org/10.15420/cfr.2024.35
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 533
  • Downloads: Downloads 36
  • Read time: 20m 9s

Finerenone: Will It Be a Game-changer?

Dinesh Khullar

,

Anish Kumar Gupta

,

Kulwant Singh

,

Published:

23 December 2024

Citation:

Cardiac Failure Review 2024;10:e19.

DOI:

https://doi.org/10.15420/cfr.2024.11
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 3271
  • Downloads: Downloads 208
  • Read time: 21m 40s